Brain endothelial cell specific integrins and ischemic stroke

References

• Takada Y, Ye X, Simon S. The integrins. Genome Biol 2007;8(5):215
   PubMed Web of Science ®Google Scholar
• Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics – 2014 update: a report from the American Heart Association. Circulation 2014;129(3):399-410
   PubMed Web of Science ®Google Scholar
• Ovbiagele B, Nguyen-Huynh MN. Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics 2011;8(3):319-29
   PubMed Web of Science ®Google Scholar
• Thrift AG, Cadilhac DA, Thayabaranathan T, et al. Global stroke statistics. Int J Stroke 2014;9(1):6-18
   PubMed Web of Science ®Google Scholar
• The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333(24):1581-7
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acutehemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274(13):1017-25
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352(9136):1245-51
   PubMed Web of Science ®Google Scholar
• del Zoppo GJ, Sharp FR, Heiss WD, Albers GW. Heterogeneity in the penumbra. J Cereb Blood Flow Metab 2011;31(9):1836-51
   PubMed Web of Science ®Google Scholar
• Tagaya M, Haring H, Stuiver I, et al. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab 2001;21:835-46
   PubMed Web of Science ®Google Scholar
• Langhauser F, Kraft P, Gob E, et al. Blocking of alpha4 integrin does not protect from acute ischemic stroke in mice. Stroke 2014;45(6):1799-806
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Onodera H, Shiga Y, et al. Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res 1994;656(2):344-52
   PubMed Web of Science ®Google Scholar
• Fischer S, Wobben M, Marti HH, et al. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 2002;63(1):70-80
   PubMed Web of Science ®Google Scholar
• Tuttolomondo A, Di Raimondo D, Pecoraro R, et al. Inflammation in ischemic stroke subtypes. Curr Pharm Des 2012;18(28):4289-310
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Proinflammatory cytokines. Chest 2000;118:503-8
   PubMed Web of Science ®Google Scholar
• Mena MP, Papiewska-Pajak I, Przygodzka P, et al. NFAT2 regulates COX-2 expression and modulates the integrin repertoire in endothelial cells at the crossroads of angiogenesis and inflammation. Exp Cell Res 2014;324(2):124-36
   PubMed Web of Science ®Google Scholar
• Tuttolomondo A, Pinto A, Corrao S, et al. Immuno-inflammatory and thrombotic/fibrinolytic variables associated with acute ischemic stroke diagnosis. Atherosclerosis 2009;203(2):503-8
   PubMed Web of Science ®Google Scholar
• Davì G, Tuttolomondo A, Santilli F, et al. CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. J Atheroscler Thromb 2009;16:707-13
   PubMed Web of Science ®Google Scholar
• Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 2008;32(2):200-19
   PubMed Web of Science ®Google Scholar
• Osada T, Gu YH, Kanazawa M, et al. Interendothelial claudin-5 expression depends on cerebral endothelial cell-matrix adhesion by beta(1)-integrins. J Cereb Blood Flow Metab 2011;31(10):1972-85
   PubMed Web of Science ®Google Scholar
• Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 2004;16(1):1-13
   PubMed Web of Science ®Google Scholar
• Krupinski J, Kaluza J, Kumar P, et al. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994;25(9):1794-8
   PubMed Web of Science ®Google Scholar
• Hayakawa K, Pham LD, Arai K, Lo EH. Reactive astrocytes promote adhesive interactions between brain endothelium and endothelial progenitor cells via HMGB1 and beta-2 integrin signaling. Stem Cell Res 2014;12(2):531-8
   PubMed Web of Science ®Google Scholar
• Welser-Alves JV, Boroujerdi A, Tigges U, et al. Endothelial beta4 integrin is predominantly expressed in arterioles, where it promotes vascular remodeling in the hypoxic brain. Arterioscler Thromb Vasc Biol 2013;33(5):943-53
   PubMed Web of Science ®Google Scholar
• Haring HP, Akamine P, Habermann R, et al. Distribution of Integrin-like Immunoreactivity on Primate Brain Microvasculature. J Neuro Exp Neurol 1996;55(2):236-45
   PubMed Web of Science ®Google Scholar
• Bloch W, Forsberg E, Lentini S, et al. Beta 1 integrin is essential for teratoma growth and angiogenesis. J Cell Biol 1997;139:265-78
   PubMed Web of Science ®Google Scholar
• Milner R. Developmental regulation of β1 integrins during angiogenesis in the central nervous system. Mol Cell Neurosci 2002;20(4):616-26
   PubMed Web of Science ®Google Scholar
• Meredith JE, Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993;4:953-61
   PubMed Web of Science ®Google Scholar
• Li L, Welser JV, Milner R. Absence of the alpha v beta 3 integrin dictates the time-course of angiogenesis in the hypoxic central nervous system: accelerated endothelial proliferation correlates with compensatory increases in alpha 5 beta 1 integrin expression. J Cereb Blood Flow Metab 2010;30(5):1031-43
   PubMed Web of Science ®Google Scholar
• Bader BL, Rayburn H, Crowley D, Hynes RO. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality lacking all alpha v integrins. Cell 1998;95:507-19
   PubMed Web of Science ®Google Scholar
• Milner R, Hung S, Erokwu B, et al. Increased expression of fibronectin and the alpha 5 beta 1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia. Mol Cell Neurosci 2008;38(1):43-52
   PubMed Web of Science ®Google Scholar
• Mettouchi A, Klein S, Guo W, et al. Integrin-specific activation of Rac controls progression through the G1 phase of the cell cycle. Mol Cell 2001;8:115-27
   PubMed Web of Science ®Google Scholar
• Kim S, Harris M, Varner JA. Regulation of integrin alpha v beta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A. J Biol Chem 2000;275(43):33920-8
   PubMed Web of Science ®Google Scholar
• Li L, Welser-Alves J, van der Flier A, et al. An angiogenic role for the alpha5beta1 integrin in promoting endothelial cell proliferation during cerebral hypoxia. Exp Neurol 2012;237(1):46-54
   PubMed Web of Science ®Google Scholar
• Francis SE. Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol 2002;22(6):927-33
   PubMed Web of Science ®Google Scholar
• Klein S, de Fougerolles AR, Blaikie P, et al. 5 1 integrin activates an NF- B-dependent program of gene expression important for angiogenesis and inflammation. Mol Cell Biol 2002;22(16):5912-22
   PubMed Web of Science ®Google Scholar
• Milner R, Campbell I. Increased expression of the B4 and a5 integrin subunits in cerebral blood vessels of transgenic mice chronically producing the pro-inflammatory cytokines IL-6 or IFN-a in the central nervous system. Mol Cell Neurosci 2006;33(4):429-40
   PubMed Web of Science ®Google Scholar
• Lathia JD, Chigurupati S, Thundyil J, et al. Pivotal role for beta-1 integrin in neurovascular remodeling after ischemic stroke. Exp Neurol 2010;221(1):107-14
   PubMed Web of Science ®Google Scholar
• O’Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metasteses by a Lewis lung carcinoma. Cell 1994;79:315-28
   PubMed Web of Science ®Google Scholar
• Pozzi A, Wary KK, Giancotti FG, et al. Integrin alpha1beta1 mediates a unique collagen-dependent proliferation pathway in vivo. J Cell Biol 1998;142:587-94
   PubMed Web of Science ®Google Scholar
• Mettouchi A, Meneguzzi G. Distinct roles of beta1 integrins during angiogenesis. Eur J Cell Biol 2006;85(3-4):243-7
   PubMed Web of Science ®Google Scholar
• Abumiya T, Lucero J, Heo JH, et al. Activated microvessels express vascular endothelial growth factor and integrin alpha v beta 3 during focal cerebral ischemia. J Cereb Blood Flow Metab 1999;19:1038-50
   PubMed Web of Science ®Google Scholar
• del Zoppo GJ, Milner R, Mabuchi T, et al. Vascular matrix adhesion and the blood-brain barrier. International Symposium on Neurodegeneration and Neuroprotection; University of Münster, Germany; 2006
   Google Scholar
• del Zoppo GJ, Milner R. Integrin-matrix interactions in the cerebral microvasculature. Arterioscler Thromb Vasc Biol 2006;26(9):1966-75
   PubMed Web of Science ®Google Scholar
• Wang J, Milner R. Fibronectin promotes brain capillary endothelial cell survival and proliferation through alpha5beta1 and alphavbeta3 integrins via MAP kinase signaling. J Neurochem 2006;96(1):148-59
   PubMed Web of Science ®Google Scholar
• Shimamura N, Matchett G, Yatsushige H, et al. Inhibition of integrin alphavbeta3 ameliorates focal cerebral ischemic damage in the rat middle cerebral artery occlusion model. Stroke 2006;37(7):1902-9
   PubMed Web of Science ®Google Scholar
• Shimamura N, Matchett G, Solaroglu I, et al. Inhibition of integrin alphavbeta3 reduces blood-brain barrier breakdown in focal ischemia in rats. J Neurosci Res 2006;84(8):1837-47
   PubMed Web of Science ®Google Scholar
• Boroujerdi A, Welser-Alves JV, Tigges U, Milner R. Chronic cerebral hypoxia promotes arteriogenic remodeling events that can be identified by reduced endoglin (CD105) expression and a switch in beta1 integrins. J Cereb Blood Flow Metab 2012;32(9):1820-30
   PubMed Web of Science ®Google Scholar
• Okada Y, Copeland BR, Hamann GF, et al. Integrin avb3, is expressed in selected microvessels following focal cerebral ischemia. Am J Pathol 1996;49(1):37-44
   Google Scholar
• Polman CH, O’Connor PW, Havrdova E, et al. A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis. N Engl J Med 2006;354(9):899-910
   PubMed Web of Science ®Google Scholar
• Kleinschnitz C, Grund H, Wingler K, et al. Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol 2010;8:9
   PubMed Web of Science ®Google Scholar
• Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the Atlantis study: A randomized controlled trial. JAMA 1999;282:1245-51
   Web of Science ®Google Scholar
• del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a Phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29(1):4-11
   PubMed Web of Science ®Google Scholar
• Furlan A, Higashida RT, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. JAMA 1999;282(21):2003-11
   PubMed Web of Science ®Google Scholar
• Investigators IIT. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38(7):2127-35
   PubMed Web of Science ®Google Scholar
• Shireman TI, Howard PA, Kresowik TF, Ellerbeck EF. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke 2004;35(10):2362-7
   PubMed Web of Science ®Google Scholar
• Dahlman J. A lesson in communication. Nat Nanotechnol 2014;9(8):656
   PubMed Web of Science ®Google Scholar
• Kiessling JW, Cines DB, Higazi A, Armstead WM. Inhibition of integrin avb3 prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia. Am J Physiol Heart Circ Physiol 2009;296(3):H862-7
   Web of Science ®Google Scholar